Navigation Links
Queen bee or worker bee? New insights into famous honeybee society caste system
Date:9/21/2011

Scientists are reporting deep new insights into whys and hows of the famous caste system that dominates honey bee societies, with a select few bee larvae destined for royalty and the masses for worker status. Their study probing the innermost biological makings of queen bees and worker bees appears in ACS's Journal of Proteome Research.

Jianke Li and colleagues (The joint work of scientists from China and Ethiopia) note that despite more than a century of research, mysteries remain about the biochemical factors at the basis of the fascinating caste system in honeybee colonies. Schoolchildren learn that the (usually) one queen bee in a colony develops from larvae fed royal jelly, a protein-rich secretion from glands on the heads of worker bees. Other larvae develop into female workers or male drones. Although queen and worker bees share almost identical genes, their destinies could be more different. "The female queen is large in size and specializes in reproduction," the scientists explain, "whereas workers are small and engage in colony-maintaining activities. Their life spans also vary, with the queen living for 1 to 2 years and the workers living only 6 to 7 weeks. To gain further information, the scientists looked at proteins inside the cells of larvae destined for queen and worker status.

Their findings reveal major differences, during early stages of life, in the activity of proteins in the mitochondria, structures that produce energy for cells. The differences include changes in the amounts of protein produced in cells and the activity of those proteins. In pre-queen larvae, proteins involved in carbohydrate and energy metabolism, for instance, are much more active than in workers. "This suggests proteins with metabolic enhancing activities generally appear to have significant roles in the process of caste determination," the researchers conclude.


'/>"/>

Contact: Michael Bernstein
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Trauma drama: K-State professor researches drama queen of immune system
2. Clemson University and the University of Queensland form biofuels research partnership
3. Queens University scientists behind safer drinking water in US
4. Shellfish safer to eat thanks to breakthrough by Queens scientists
5. When it comes to selecting a mate, the eyes have it: Queens University study
6. Queens life-saving research wins education Oscar
7. Technology developed at Queens University allows medical workers to better assess brain injuries
8. Queens University Belfast lung injury study could save lives in critically ill
9. Discovery may lead to safer drinking water, cheaper medicine: Queens University researchers
10. Queens researchers reveal parasitic threat to animals and the environment
11. The making of a queen: Road to royalty begins early in paper wasps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
(Date:11/28/2016)... -- "The biometric system market projected ... biometric system market is in the growth stage and ... The biometric system market is expected to be valued ... of 16.79% between 2016 and 2022. Government initiative in ... smartphones, rising use of biometric technology in financial institutes ...
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... CALGARY , Dec. 5, 2016 /PRNewswire/ - ... announced  that the independent Data and Safety Monitoring ... trial in high-risk cardiovascular disease (CVD) patients has ... that the study should continue as planned without ... and noted that no safety or efficacy concerns ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/5/2016)... -- The U.S. Biotechnology industry is the ... revenue and some $890 billion of total market value. In ... and this figure is expected to exceed $220 billion ... four equities for assessment: Northwest Biotherapeutics Inc. (NASDAQ: ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ACOR ...
(Date:12/4/2016)... ... 03, 2016 , ... Microbial genomics leader uBiome is awarding ... been made to Dr. Renato Polimanti of Yale University School of Medicine, who ... Grant proposals have been vetted by the company’s scientific review committee. , ...
Breaking Biology Technology: